SynAct Pharma AB · OMXSTO:SYNACT
Boesen Biotech ApS bought 5,450 SynAct Pharma AB shares (MAR article 19 notification)
Traded Mar 3, 2026 · Filed Mar 6, 2026 · Read by 6ix Oct 14, 2026
On Mar 3, 2026, Boesen Biotech ApS (Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)) bought 5,450 SynAct Pharma AB shares at an average SEK 17.91 for SEK 97,610. Filed Mar 6, 2026 (MAR article 19 notification).
- Bought
- 5,450 shares
- Price
- SEK 17.91 average (SEK 17.90 to SEK 17.92)
- Value
- SEK 97,610
- Role
- Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)
The register entry
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | SynAct Pharma AB | Buy | 2,700 | SEK 17.90 | Indirect | |
| Mar 3, 2026 | SynAct Pharma AB | Buy | 2,750 | SEK 17.92 | Indirect |
Source
View original at Finansinspektionen
Related
- SynAct Pharma AB
- Boesen Biotech ApS
- SynAct Pharma AB shareholders
- MAR article 19 notification · Quantass ApS · Nov 18, 2026
- MAR article 19 notification · TJ Biotech Holding ApS · Sep 7, 2026
- MAR article 19 notification · Quantass ApS · Sep 7, 2026
- MAR article 19 notification · Anders Kronborg · Mar 10, 2026
- MAR article 19 notification · Quantass ApS · Mar 9, 2026